Literature DB >> 3123178

Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis.

D Müting1, J F Kalk, R Fischer, H Wuzel, J Reikowski.   

Abstract

The detoxification capacity of the liver in chronic active hepatitis (CAH) without liver cirrhosis (LC) is not sufficiently known. Therefore, we examined, in 156 patients with morphologically proven CAH of different stages, plasma ammonia, free phenols, indican, glucuronic acid and urea synthesis rate as parameters for liver detoxification. We found a significant increase of ammonia, phenols, and indican and a significant decrease of glucuronic acid and urea synthesis rate parallel to the stage of CAH without LC. In 34 CAH patients with complete recovery, a retrospective 10-year follow-up was possible. Parallel to the normalization of liver morphology and general liver tests, detoxification parameters also normalized. However, the detoxification disorders in CAH without LC are mild in nature and do not produce hepatic encephalopathy. Probably, they are caused by a reduced synthesis of the urea-cycle enzymes and of glucuronyltransferase in the liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123178     DOI: 10.1007/bf01536629

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Urinary phenols; the simultaneous determination of phenol and p-cresol in urine.

Authors:  E G SCHMIDT
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

2.  Intrahepatic arteriovenous shunting in cirrhosis of the liver.

Authors:  R J Groszmann; D Kravetz; O Parysow
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

3.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

4.  Hepatogenic cyanosis: arteriovenous shunts in chronic active hepatitis.

Authors:  R E Kravath; E M Scarpelli; J Bernstein
Journal:  J Pediatr       Date:  1971-02       Impact factor: 4.406

5.  Activities of urea-cycle enzymes in chronic liver disease.

Authors:  K P Maier; H Talke; W Gerok
Journal:  Klin Wochenschr       Date:  1979-07-03

6.  Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5'-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes.

Authors:  S Matern; H Matern; E H Farthmann; W Gerok
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Treatment of chronic active hepatitis--present state.

Authors:  D Müting; G Winter; R Fischer; J F Kalk
Journal:  Hepatogastroenterology       Date:  1984-02

8.  Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects.

Authors:  D Rudman; T J DiFulco; J T Galambos; R B Smith; A A Salam; W D Warren
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  Portal hypertension in chronic hepatitis--comparative manometric and clinico-chemical examinations.

Authors:  M Möhrl; L Wannagat; D Gehring
Journal:  Klin Wochenschr       Date:  1980-02-15

10.  Chronic hepatitis: a problem for the pathologist.

Authors:  P J Scheuer
Journal:  Histopathology       Date:  1977-01       Impact factor: 5.087

View more
  6 in total

Review 1.  Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.

Authors:  Alexander J Prokopienko; Thomas D Nolin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-09-20       Impact factor: 5.045

2.  Neurokinin A increases short-circuit current across rat colonic mucosa: a role for vasoactive intestinal polypeptide.

Authors:  X Y Tien; L J Wallace; J F Kachur; S Won-Kim; T S Gaginella
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

3.  A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.

Authors:  Ya-Nan Song; Jian Chen; Fei-Fei Cai; Yi-Yu Lu; Qi-Long Chen; Yong-Yu Zhang; Ping Liu; Shi-Bing Su
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

4.  Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model.

Authors:  Prue M Pereira-Fantini; Sean G Byars; James Pitt; Susan Lapthorne; Fiona Fouhy; Paul D Cotter; Julie E Bines
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

5.  Circulating glucuronic acid predicts healthspan and longevity in humans and mice.

Authors:  Andrew Ho; Jonah Sinick; Tõnu Esko; Krista Fischer; Cristina Menni; Jonas Zierer; Maria Matey-Hernandez; Kristen Fortney; Eric K Morgen
Journal:  Aging (Albany NY)       Date:  2019-09-26       Impact factor: 5.682

6.  Functional metabolomics discover pentose and glucuronate interconversion pathways as promising targets for Yang Huang syndrome treatment with Yinchenhao Tang.

Authors:  Hui Sun; Ai-Hua Zhang; Qi Song; Heng Fang; Xing-Yuan Liu; Jing Su; Le Yang; Meng-Die Yu; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-10-31       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.